Butchko Julia G.'s Form 4 filing
Immunovant, Inc. (IMVT) · filed Oct 6, 2023
- Accession no.
- 0001764013-23-000118
- Filed
- Oct 6, 2023
- Trade date
- Oct 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $62.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butchko Julia G.CIK 0001796290 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2023 | Common Stock | SSaleDisposed | −296 | $35.54 | −$10,519.84 | 415,964 | Direct | |
| Oct 5, 2023 | Common Stock | SSaleDisposed | −1,439 | $36.39 | −$52,365.21 | 414,525 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.